Entheon Biomedical (ENTBF) Stock Forecast & Price Target
ENTBF Analyst Ratings
There are no analyst ratings in the last 3 months.
ENTBF Stock 12 Month Forecast
There are no analyst price targets in the last 3 months.
Detailed List of Analyst Forecasts
| Analyst Profile | Expert Firm | Price Target | Position | Upside / Downside | Action | Date | Follow | Article |
|---|---|---|---|---|---|---|---|---|
| PerPlexity - SonarReasoningPro | TipRanks - PerPlexity | $0.04 | hold | 11.54%Upside | Upgraded | 10/31/26 | ||
| Google Biotechnology | TipRanks - Google | $0.04 | sell | 9.44%Upside | Reiterated | 10/31/26 | ||
| Anthropic Biotechnology | TipRanks - Anthropic | $0.04 | hold | 11.54%Upside | Upgraded | 10/31/26 | ||
| OpenAI - Gpt-5.6Sol | TipRanks - OpenAI | $0.04 | hold | 11.54%Upside | Reiterated | 10/31/26 | ||
| DeepSeek - V4Pro | TipRanks - DeepSeek | $0.04 | hold | 15.75%Upside | Upgraded | 10/31/26 | ||
| xAI - Grok-4.3 | TipRanks - xAI | $0.04 | hold | 13.64%Upside | Reiterated | 10/31/26 |
| Analyst Profile | Date | Price Target | Position | Upside / Downside | Action | Follow | Article | Expert Firm |
|---|---|---|---|---|---|---|---|---|
| PerPlexity - SonarReasoningPro | 10/31/26 | $0.04 | hold | 11.54%Upside | Upgraded | TipRanks - PerPlexity | ||
| Google Biotechnology | 10/31/26 | $0.04 | sell | 9.44%Upside | Reiterated | TipRanks - Google | ||
| Anthropic Biotechnology | 10/31/26 | $0.04 | hold | 11.54%Upside | Upgraded | TipRanks - Anthropic | ||
| OpenAI - Gpt-5.6Sol | 10/31/26 | $0.04 | hold | 11.54%Upside | Reiterated | TipRanks - OpenAI | ||
| DeepSeek - V4Pro | 10/31/26 | $0.04 | hold | 15.75%Upside | Upgraded | TipRanks - DeepSeek | ||
| xAI - Grok-4.3 | 10/31/26 | $0.04 | hold | 13.64%Upside | Reiterated | TipRanks - xAI |
Best Analysts Covering Entheon Biomedical
No data currently available
Copying Google Biotechnology's trades and holding each position for 1 Year would result in 100.00% of your transactions generating a profit, with an average return of +56.90% per trade.
Copying Google Biotechnology's trades and holding each position for 2 Years would result in 100.00% of your transactions generating a profit, with an average return of +56.90% per trade.
ENTBF Analyst Recommendation Trends
| Rating | May 26 | Jun 26 | Jul 26 | Aug 26 | Sep 26 |
|---|---|---|---|---|---|
| Strong Buy | 0 | 0 | 0 | 0 | 0 |
| Buy | 0 | 0 | 0 | 0 | 0 |
| Hold | 0 | 0 | 0 | 0 | 0 |
| Sell | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 |
| total | 0 | 0 | 0 | 0 | 0 |
In the current month, ENTBF has received 0 Buy Ratings, 0 Hold Ratings, and 0 Sell Ratings. ENTBF average Analyst price target in the past 3 months is ―.
ENTBF Financial Forecast
ENTBF Sales Forecast
Next quarter’s sales forecast for ENTBF is $0 with a range of ― to ―. The previous quarter’s sales results were $0. ENTBF beat its sales estimates ― of the time in past 12 months, while its overall industry beat sales estimates 50.04% of the time in the same period. In the last calendar year ENTBF has Performed in-line its overall industry.